AbCellera Biologics (ABCL) News Today $4.42 +0.19 (+4.59%) As of 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ABCL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Truist Financial Reiterates a Buy Rating on AbCellera Biologics (ABCL), Sets a $10 PTAugust 26 at 5:12 AM | msn.comAbCellera Biologics (ABCL) Advances Proprietary Pipeline with Promising Phase 1 Trial ResultsAugust 17, 2025 | msn.comAbCellera Biologics (NASDAQ:ABCL) Upgraded by Wall Street Zen to Hold RatingAugust 17, 2025 | americanbankingnews.comAbCellera Biologics (NASDAQ:ABCL) Raised to "Hold" at Wall Street ZenAugust 17, 2025 | marketbeat.comTruist Financial Reaffirms Their Buy Rating on AbCellera Biologics (ABCL)August 16, 2025 | theglobeandmail.comAbCellera to Participate at Upcoming Investor Conferences in SeptemberAugust 12, 2025 | businesswire.comAbCellera Biologics (NASDAQ:ABCL) Shares Up 7.9% - What's Next?August 12, 2025 | marketbeat.comIndustry Analysts Just Made A Huge Upgrade To Their AbCellera Biologics Inc. (NASDAQ:ABCL) Revenue ForecastsAugust 12, 2025 | finance.yahoo.comAbCellera Biologics (NASDAQ:ABCL) Announces Earnings ResultsAugust 10, 2025 | marketbeat.comAbCellera Biologics Inc. (NASDAQ:ABCL) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | msn.comAbCellera Biologics (NASDAQ:ABCL) Shares Gap Up on Earnings BeatAugust 9, 2025 | marketbeat.comStifel Nicolaus Cuts AbCellera Biologics (NASDAQ:ABCL) Price Target to $7.00August 9, 2025 | marketbeat.comAbCellera Biologics (ABCL) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | fool.comAbCellera soars as revenue more than doubles estimatesAugust 8, 2025 | in.investing.comAbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call TranscriptAugust 7, 2025 | seekingalpha.comAbCellera Biologics Inc. (NASDAQ:ABCL) Shares Sold by GSA Capital Partners LLPAugust 4, 2025 | marketbeat.comAbCellera Biologics Inc. (NASDAQ:ABCL) Given Average Rating of "Buy" by AnalystsAugust 3, 2025 | marketbeat.comPiper Sandler Reiterates a Buy Rating on AbCellera Biologics (ABCL)July 31, 2025 | msn.comInstitutional owners may ignore AbCellera Biologics Inc.'s (NASDAQ:ABCL) recent US$125m market cap decline as longer-term profits stay in the greenJuly 31, 2025 | finance.yahoo.comAbCellera Biologics (ABCL) to Release Quarterly Earnings on ThursdayJuly 31, 2025 | marketbeat.comAbCellera Biologics (ABCL) Gets a Buy from Piper SandlerJuly 30, 2025 | theglobeandmail.comBaillie Gifford & Co. Lowers Stake in AbCellera Biologics Inc. (NASDAQ:ABCL)July 27, 2025 | marketbeat.comAbCellera: Just Another Biotech StockJuly 23, 2025 | seekingalpha.comLeerink Partners Affirms Outperform Rating on AbCellera Biologics (ABCL) Following PivotJuly 23, 2025 | msn.comAbCellera Biologics (NASDAQ:ABCL) Sets New 12-Month High - Here's What HappenedJuly 21, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Sets New 52-Week High After Analyst UpgradeJuly 15, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Stock Price Up 8.9% on Analyst UpgradeJuly 14, 2025 | marketbeat.comKeyCorp Boosts AbCellera Biologics (NASDAQ:ABCL) Price Target to $10.00July 14, 2025 | marketbeat.comMoloney Securities Asset Management LLC Reduces Stake in AbCellera Biologics Inc. (NASDAQ:ABCL)July 12, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Reaches New 52-Week High - Should You Buy?July 9, 2025 | marketbeat.comResearch Analysts Set Expectations for ABCL Q2 EarningsJuly 9, 2025 | marketbeat.comTruist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy RatingJuly 8, 2025 | msn.comAbCellera Biologics Inc. (NASDAQ:ABCL) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 8, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Upgraded at Leerink PartnrsJuly 8, 2025 | marketbeat.comAbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025July 7, 2025 | businesswire.comAbCellera Biologics (NASDAQ:ABCL) Trading Up 6.2% - Should You Buy?July 7, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Coverage Initiated by Analysts at Leerink PartnersJuly 7, 2025 | marketbeat.comWe're Interested To See How AbCellera Biologics (NASDAQ:ABCL) Uses Its Cash Hoard To GrowJune 30, 2025 | finance.yahoo.comAbCellera Biologics (NASDAQ:ABCL) Sets New 52-Week High - Should You Buy?June 25, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Shares Up 8% - Time to Buy?June 24, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Shares Down 4.9% - Time to Sell?June 20, 2025 | marketbeat.comAbCellera Biologics: The Dilemma Of A Promising Pipeline Alongside Cash BurnJune 13, 2025 | seekingalpha.comAbCellera Biologics (NASDAQ:ABCL) Shares Gap Down - Should You Sell?June 13, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Shares Gap Up - Time to Buy?June 11, 2025 | marketbeat.comAbCellera Biologics Inc. (ABCL): A Bull Case TheoryJune 10, 2025 | finance.yahoo.comAbCellera Biologics (NASDAQ:ABCL) Stock Price Up 10.6% - Should You Buy?June 10, 2025 | marketbeat.comAbCellera Biologics (NASDAQ:ABCL) Stock Price Up 8.9% - Here's What HappenedJune 4, 2025 | marketbeat.comWhy AbCellera Biologics Stock Raced Nearly 6% Higher TodayJune 2, 2025 | fool.comAbCellera Biologics Inc. (ABCL) Approved to Begin ABCL575 Trial for Atopic DermatitisMay 31, 2025 | insidermonkey.comAbCellera Biologics Inc. (NASDAQ:ABCL) Stock Holdings Boosted by Millennium Management LLCMay 31, 2025 | marketbeat.com Get AbCellera Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABCL and its competitors with MarketBeat's FREE daily newsletter. Email Address ABCL Media Mentions By Week ABCL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABCL News Sentiment▼0.000.70▲Average Medical News Sentiment ABCL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABCL Articles This Week▼13▲ABCL Articles Average Week Get AbCellera Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ABCL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Axsome Therapeutics News Today Nuvalent News Today Abivax News Today CRISPR Therapeutics News Today Merus News Today Viking Therapeutics News Today Cytokinetics News Today Ascentage Pharma Group International News Today TG Therapeutics News Today Krystal Biotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ABCL) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbCellera Biologics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbCellera Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access